How to treat women with antiphospholipid antibodies in pregnancy?

Por DERKSEN, R, DE GROOT, P. G, NIEUWENHUIS, H, CHRISTIAENS, G
Publicado em 2001

NuGO contributions to GenePattern

Por De Groot, P. J., Reiff, C., Mayer, C., Müller, M.
Publicado em 2008

Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment.

Por Derksen, R H, de Groot, P G, Kater, L, Nieuwenhuis, H K
Publicado em 1993

Treatment of women with aPL in pregnancy

Por FIEHN, C, DERKSEN, R, DE GROOT, P G, NIEUWENHUIS, H, CHRISTIAENS, G
Publicado em 2001

Prospective study of fluctuations of lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus.

Por Out, H J, van Vliet, M, de Groot, P G, Derksen, R H
Publicado em 1992

Evidence that the primary binding site of von Willebrand factor that mediates platelet adhesion on subendothelium is not collagen.

Por de Groot, P G, Ottenhof-Rovers, M, van Mourik, J A, Sixma, J J
Publicado em 1988

Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.

Por Derksen, R H, Hasselaar, P, Blokzijl, L, Gmelig Meyling, F H, De Groot, P G
Publicado em 1988

Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study.

Por Out, H J, de Groot, P G, Hasselaar, P, dan Vliet, M, Derksen, R H
Publicado em 1989

Binding of recombinant annexin V to endothelial cells: effect of annexin V binding on endothelial-cell-mediated thrombin formation.

Por van Heerde, W L, Poort, S, van 't Veer, C, Reutelingsperger, C P, de Groot, P G
Publicado em 1994

Protein C activation on endothelial cells by prothrombin activation products generated in situ: meizothrombin is a better protein C activator than alpha-thrombin.

Por Hackeng, T M, Tans, G, Koppelman, S J, de Groot, P G, Rosing, J, Bouma, B N
Publicado em 1996

Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins.

Por Agbanyo, F R, Sixma, J J, de Groot, P G, Languino, L R, Plow, E F
Publicado em 1993

Absence of ligands bound to glycoprotein IIB-IIIA on the exposed surface of a thrombus may limit thrombus growth in flowing blood.

Por Heynen, H F, Lozano Molero, M, de Groot, P G, Nieuwenhuis, H K, Sixma, J J
Publicado em 1994

Isolation of expressed sequence tags of Agaricus bisporus and their assignment to chromosomes.

Por Sonnenberg, A S, de Groot, P W, Schaap, P J, Baars, J J, Visser, J, Van Griensven, L J
Publicado em 1996

Flux Exclusion Superconducting Quantum Metamaterial: Towards Quantum-level Switching

Por Savinov, V., Tsiatmas, A., Buckingham, A. R., Fedotov, V. A., de Groot, P. A. J., Zheludev, N. I.
Publicado em 2012

Risk factors for thrombosis in lupus patients.

Por Hasselaar, P, Derksen, R H, Blokzijl, L, Hessing, M, Nieuwenhuis, H K, Bouma, B N, De Groot, P G
Publicado em 1989

von Willebrand factor synthesized by endothelial cells from a patient with type IIB von Willebrand disease supports platelet adhesion normally but has an increased affinity for pla...

Por de Groot, P G, Federici, A B, de Boer, H C, d'Alessio, P, Mannucci, P M, Sixma, J J
Publicado em 1989

Increased platelet deposition on atherosclerotic coronary arteries.

Por van Zanten, G H, de Graaf, S, Slootweg, P J, Heijnen, H F, Connolly, T M, de Groot, P G, Sixma, J J
Publicado em 1994

Brain gangliosides in the presenile dementia of Pick.

Por Kamp, P E, den Hartog Jager, W A, Maathuis, J, de Groot, P A, de Jong, J M, Bolhuis, P A
Publicado em 1986

Prevalence of antiphospholipid antibodies in patients with fetal loss.

Por Out, H J, Bruinse, H W, Christiaens, G C, van Vliet, M, Meilof, J F, de Groot, P G, Smeenk, R J, Derksen, R H
Publicado em 1991

Annexin A5 polymorphism (−1C→T) and the presence of anti‐annexin A5 antibodies in the antiphospholipid syndrome

Por de Laat, B, Derksen, R H W M, Mackie, I J, Roest, M, Schoormans, S, Woodhams, B J, de Groot, P G, van Heerde, W L
Publicado em 2006